Planning Operative Strategy Using a Digital Renal Artery Clamping Tool: a Randomized Controlled Trial Evaluating the DIPLANN 3D Model for Selective Arterial Clamping During Robot-Assisted Partial Nephrectomy

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Device, Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A proposed new tool ('DIPLANN-tool' - Digital Planning in Nephrectomy) for predicting kidney perfusion zones on a segmented 3D model during robot-assisted partial nephrectomy (RAPN) for localized renal cancer demonstrated high accuracy when planning selective clamping (SC) for RAPN. However, the tool's clinical added value still needs to be confirmed. Therefore, a randomized controlled trial using a study and control group is the preferred study design. Experimental group: the use of the DIPLANN-tool + conventional computed tomography (CT) imaging for preoperative planning and perioperative guidance during RAPN. Control group: the use of only conventional CT imaging for preoperative planning and perioperative guidance during RAPN (= current standard of care). The primary endpoint is planning and performing as planned a SC strategy. Secondary endpoints include patients' health, patients' insight and surgeons' benefits.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• aged 18 years or above

• cT1-2 N0 M0 renal mass

• planned to undergo RAPN

• multiphase CT scan with arterial phase available

• voluntary given and written informed consent

• sufficient in at least one of the study languages: Dutch, English, French

⁃ For the primary objective, SC needs to be deemed possible either according to the DIPLANN-tool in combination with conventional CT imaging or according to conventional CT imaging only, as assessed by an independent surgeon (between inclusion and randomization) who will not be involved in the RAPN surgical procedure, in order to be included in the analysis set. On the DIPLANN tool, SC is deemed feasible if \>= 90% tumor ischemia and \<= 70% renal parenchyma ischemia can be achieved. If these criteria are met, but it is technically or anatomically not feasible according to the independent surgeon to perform SC, he can deviate from these criteria and thus claim SC is not deemed possible. The results for the total population (patients in which SC is deemed possible AND impossible pre-operatively by an independent surgeon) will also be analyzed as a secondary objective.

Locations
Other Locations
Belgium
AZORG
RECRUITING
Aalst
AZ Sint-Jan
RECRUITING
Bruges
ZOL
RECRUITING
Genk
AZ Maria Middelares
RECRUITING
Ghent
Ghent University Hospital
RECRUITING
Ghent
Contact Information
Primary
Joris Vangeneugden, MD
joris.vangeneugden@ugent.be
+32 9 332 22 76
Backup
Charles Van Praet, MD, PhD
charles.vanpraet@uzgent.be
+32 9 332 22 76
Time Frame
Start Date: 2024-06-27
Estimated Completion Date: 2027-01-01
Participants
Target number of participants: 235
Treatments
Experimental: DIPLANN-tool + conventional CT imaging
Pre-operative planning and peri-operative guidance with DIPLANN-tool and conventional CT imaging.
Active_comparator: Conventional CT imaging alone
Pre-operative planning and peri-operative guidance with conventional CT imaging alone (standard of care).
Related Therapeutic Areas
Sponsors
Collaborators: University Ghent, Stichting tegen Kanker
Leads: University Hospital, Ghent

This content was sourced from clinicaltrials.gov